Advertisement
News
Subscribe to MDT Magazine News

Tenet turns 2Q profit on greater revenue per visit

August 3, 2010 7:45 am | by The Associated Press | Comments

Hospital operator Tenet Healthcare Corp. on Tuesday reported a profit in the second quarter as it received more revenue per patient visit.Tenet posted net income of $25 million, or 5 cents per share. That compares with a loss of $15 million, or 3 cents per share, one year ago. Revenue rose 3...

Sun Healthcare Group offering 19.3 million shares

August 3, 2010 7:45 am | by The Associated Press | Comments

Health care facility operator Sun Healthcare Group Inc. said Tuesday it is publicly offering 19.3 million shares of common stock.The company will also give underwriters a 30-day option to buy up to 2.9 million additional shares of stock to cover any overallotments. Sun said it would use the...

PerkinElmer acquires imaging tech firm VisEn Medical

August 3, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | Comments

PerkinElmer Inc., a Waltham provider of equipment and services to support human and environment health, has bought Bedford molecular imaging technology company VisEn Medical Inc.

TOPICS:
Advertisement

AACR Hosts Molecular Diagnostics Conference in Denver, Colo.

August 3, 2010 7:34 am | by AACR | Comments

This year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and...

TOPICS:

Idera pulling in $15M financing

August 3, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Idera Pharmaceuticals Inc. is raising $15 million in a registered direct offering the Cambridge biotech has made with investors.

Accuray's CyberKnife G4 System Receives Shonin Approval

August 3, 2010 6:35 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif. , Aug. 3 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the CyberKnife® G4 Robotic Radiosurgery System to...

TOPICS:

Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity

August 3, 2010 6:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO , Aug. 3 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) announced the online publication of results from its COR-BMOD trial of Contrave® (naltrexone SR/bupropion SR) in the journal Obesity . The COR-BMOD trial evaluated intensive behavior modification (BMOD) plus...

TOPICS:

Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast

August 3, 2010 6:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO , Aug. 3 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the...

TOPICS:
Advertisement

Sirona Dental 3Q net income falls 19 percent

August 3, 2010 5:45 am | by The Associated Press | Comments

Dental equipment maker Sirona Dental Systems Inc. said Tuesday its fiscal third-quarter net income fell 19 percent on higher expenses.The company reported net income of $16.6 million, or 29 cents per share, for the three months ended June 30, down from $20.5 million, or 37 cents per share, a...

Genzyme reportedly in buyout talks with Sanofi

August 3, 2010 5:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. and French drug maker Sanofi-Aventis are in talks over a possible sale, according to several reports. The news comes after weeks of speculation, prompted first by comments from Sanofi CEO Chris Viehbacher that it was in the market to buy a company worth about $20 billion.

FDA Summary of Safety and Effectiveness Data (SSED) Clinical Section Checklist

August 3, 2010 5:31 am | by U.S. Food & Drug Administration | Comments

The Summary of Safety and Effectiveness (SSED) is a document mandated by the Food, Drug and Cosmetic Act subparagraph 520(h)(1)(A) to be publicly available upon issuance of an approval order of a premarket approval application (PMA).

TOPICS:

Federal Register: Medical Device User Fee Rates for Fiscal Year 2011

August 3, 2010 5:31 am | by U.S. Food & Drug Administration | Comments

The FDA is announcing the fee rates and payment procedures for medical device user fees for fiscal year (FY) 2011. The Federal Food, Drug, and Cosmetic Act (the act), as amended by the Medical Device User Fee Amendments of 2007 (title II of the Food and..

TOPICS:

AACR to Ring Opening Bell at NASDAQ Stock Market

August 3, 2010 4:35 am | by AACR | Comments

PHILADELPHIA – The American Association for Cancer Research's Chief Executive Officer, Margaret Foti, Ph.D., M.D. (h.c.), along with other AACR representatives, will ring the opening bell at the NASDAQ Stock Market on Tuesday, August 3, signaling the start of the day's trading. The...

TOPICS:

China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010

August 3, 2010 4:35 am | by Bio-Medicine.Org | Comments

HAIKOU CITY, China , Aug. 3 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI ), which develops, manufactures, and markets specialty pharmaceutical products in China , today announced that it plans to release its second quarter 2010 financial...

TOPICS:

Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating

August 3, 2010 4:35 am | by Boston Scientific | Comments

EVOLVE trial to evaluate Company's fourth-generation SYNERGY™ drug-eluting coronary stent

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading